Moy B, Rumble RB, Carey LA. Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update. J Clin Oncol 2022 Aug 4:JCO2201533. doi: 10.1200/JCO.22.01533.
PMID: 35926153